1. Home
  2. FEAM vs PMVP Comparison

FEAM vs PMVP Comparison

Compare FEAM & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 5E Advanced Materials Inc.

FEAM

5E Advanced Materials Inc.

HOLD

Current Price

$1.48

Market Cap

70.2M

Sector

Industrials

ML Signal

HOLD

Logo PMV Pharmaceuticals Inc.

PMVP

PMV Pharmaceuticals Inc.

HOLD

Current Price

$1.24

Market Cap

76.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEAM
PMVP
Founded
2016
2013
Country
United States
United States
Employees
35
N/A
Industry
Major Chemicals
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.2M
76.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FEAM
PMVP
Price
$1.48
$1.24
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$6.38
N/A
AVG Volume (30 Days)
197.1K
286.3K
Earning Date
05-20-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.17
$1.02
52 Week High
$7.50
$1.88

Technical Indicators

Market Signals
Indicator
FEAM
PMVP
Relative Strength Index (RSI) 45.82 52.17
Support Level $1.48 $1.05
Resistance Level $2.10 $1.26
Average True Range (ATR) 0.12 0.07
MACD -0.01 0.03
Stochastic Oscillator 49.01 62.30

Price Performance

Historical Comparison
FEAM
PMVP

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

Share on Social Networks: